2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

For years, a Southside Virginia couple has relied on the Rite Aid in Lawrenceville for pharmacy services. But in June, the ...

Diethylstilbestrol (DES) was prescribed to pregnant women from 1940 to the 1970s to prevent miscarriage, premature labour and pregnancy complications.

The prescription discount card promised by Gov. Katie Hobbs is now available. It will be up to Arizonans to decide whether it ...

Health-care companies rose amid deal activity. Kimberly-Clark agreed to buy over-the-counter drug maker Kenvue for more than $40 billion, combining the maker of Huggies diapers with the owner of ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Supreme Produce brand peaches distributed between September and October, have been recalled by the Food and Drug ...

The funding to opioid addition treatment programs is one of the first publicly announced allocations of the millions of dollars available to Iowa through a national settlement against pharmaceutical c ...

The new lawsuit argues that the board’s action conflicted with federal patent laws by not allowing the company to charge as ...

Dr. Mehmet Oz and Dr. Marty Makary touted that reducing steps for biosimilar approval will lower costs by increasing competition.

Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.

From prescription medications that promise life-changing results to vitamin supplements that promote natural wellness, the options are endless — and so are the risks.